水汽
发表于 2025-3-25 05:32:43
Beispiel: Steuerung einer Bergbahnficult to design therapeutic agents that do not overlap with the physiologic activities of the normal human tissues. The recognition of a myriad of distinct adverse effects related to the molecularly targeted therapies has emerged over the last decade with their increased clinical usage.
无可争辩
发表于 2025-3-25 09:19:37
http://reply.papertrans.cn/23/2282/228135/228135_22.png
珊瑚
发表于 2025-3-25 14:57:53
Principles of Clinical Epidemiology,readers with some basic knowledge to allow them to judge the value of clinical epidemiological papers and thus of the pillars of evidence-based clinical guidelines. Examples from ocular oncology will be used to illustrate the methodological principles.
Basal-Ganglia
发表于 2025-3-25 17:46:11
http://reply.papertrans.cn/23/2282/228135/228135_24.png
过度
发表于 2025-3-25 23:01:23
http://reply.papertrans.cn/23/2282/228135/228135_25.png
权宜之计
发表于 2025-3-26 00:25:18
Book 2014Latest editioncate required information quickly owing to the clinically focused and user-friendly format. This volume provides essential information on cancer epidemiology, etiology, pathology, angiogenesis, immunology, genetics, and staging systems and explains the principles underlying different therapeutic approaches.
Pamphlet
发表于 2025-3-26 07:18:35
http://reply.papertrans.cn/23/2282/228135/228135_27.png
slow-wave-sleep
发表于 2025-3-26 12:32:45
https://doi.org/10.1007/3-211-38090-6 mechanism(s) of tumor angiogenesis, current applications in general and more specifically in ophthalmic oncology, and experimental drugs with potential for clinical applications. The final section of this review deals with angiogenic aspects of a few specific ophthalmic tumors.
archenemy
发表于 2025-3-26 14:41:36
http://reply.papertrans.cn/23/2282/228135/228135_29.png
SMART
发表于 2025-3-26 18:40:16
Cancer Angiogenesis, mechanism(s) of tumor angiogenesis, current applications in general and more specifically in ophthalmic oncology, and experimental drugs with potential for clinical applications. The final section of this review deals with angiogenic aspects of a few specific ophthalmic tumors.